Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor

In only two years, the coronavirus disease 2019 (COVID-19) pandemic has had a devastating effect on public health all over the world and caused irreparable economic damage across all countries. Due to the limited therapeutic management of COVID-19 and the lack of tailor-made antiviral agents, findin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Veronika Nemethova, Petra Mazancova, Michal Selc, Kristina Jakic, Lucia Uhelska, Boglarka Nemethova, Alexandra Poturnayova, Lubos Drgona, Andrea Babelova, Filip Razga
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2022-03-01
Saila:Viruses
Gaiak:
SARS-CoV-2
COVID-19
RNA levels
oligonucleotide-based RNA inhibitor
RdRp
Sarrera elektronikoa:https://www.mdpi.com/1999-4915/14/4/685
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak